Atossa Genetics Inc (ATOS NASDAQ) stock market data APIs
$4.0897
0.63(15.4%)
as of February 11, 2026
Try our APIs with
free plan!
Atossa Genetics Inc Financial Data Overview
Price chart is built with
Anychart
Atossa Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company that develops medicines in the areas of unmet medical need in oncology for women breast cancer and other conditions in the United States. The company's lead drug candidate is oral (Z)-endoxifen, an active metabolite of tamoxifen, which is in Phase II clinical trials to treat and prevent breast cancer. It also develops immunotherapy/chimeric antigen receptor therapy programs. The company was formerly known as Atossa Genetics Inc. and changed its name to Atossa Therapeutics, Inc. in January 2020. Atossa Therapeutics, Inc. was founded in 2008 and is based in Seattle, Washington.
Prev. Close
4.0897
Open
4.7243
High
4.8109
Low
4.0708
52 wk Range
4.0318-19.35
Market Cap
34 876 K
Shares Outstanding
8 611 K
EPS
-0.07
Beta
1.336
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
ETFs with Atossa Genetics Inc (top by weight)
Ticker
100-day Price Change
Weight
* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Atossa Genetics Inc data using free add-ons & libraries
Get Atossa Genetics Inc Fundamental Data
Atossa Genetics Inc Fundamental data includes:
- Net Revenue:
- EBITDA: -32 840 000
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-11-12
- EPS/Forecast: -0.06
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Atossa Genetics Inc News
New
After-Hours Gainers: ATOS, IBRX, FEMY, FHTX, DARE, TBPH
(RTTNews) - Several biotech and healthcare stocks posted notable gains in after-hours trading on Friday, driven by regulatory developments, financing updates, and investor sentiment. Atossa Therapeut...
Atossa Secures FDA Orphan Drug Designation For (Z)-Endoxifen In Duchenne Muscular Dystrophy
(RTTNews) - Atossa Therapeutics, Inc. (ATOS) announced that the U.S. Food and Drug Administration's Office of Orphan Products Development (OOPD) has granted Orphan Drug Designation to (Z)-endoxifen fo...
Atossa Therapeutics shares rise after FDA grants orphan drug designation for soft tissue sarcoma
[Close-Up Shot of Scientists Hands typing Data in Laptop in Laboratory] Tom Werner * The U.S. Food and Drug Administration has granted Atossa Therapeutics’ (ATOS) treatment for soft tissue sarcom...
New Strong Sell Stocks for Oct. 14th
Here are three stocks added to the Zacks Rank #5 (Strong Sell) List today: Antero Resources AR is an independent explorer, primarily engaged in the acquisition and development of natural gas, natural...
Get Atossa Genetics Inc fresh news feed via Financial News API
$19.99/mo.
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
